Ikonisys S.A. (ALIKO.PA)
EUR 1.53
(0.66%)
EUR 1.53
(0.66%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 448.55 Thousand EUR | -52.04% |
| 2022 | 935.21 Thousand EUR | 843.73% |
| 2021 | 99.09 Thousand EUR | -0.73% |
| 2020 | 99.82 Thousand EUR | 45.88% |
| 2019 | 68.42 Thousand EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 297.54 Thousand EUR | 0.0% |
| 2023 Q2 | 128.9 Thousand EUR | 100.0% |
| 2023 FY | 448.55 Thousand EUR | -52.04% |
| 2023 Q3 | 159.82 Thousand EUR | 23.98% |
| 2023 Q1 | 64.45 Thousand EUR | -84.27% |
| 2023 Q4 | 159.82 Thousand EUR | 0.0% |
| 2022 Q3 | 204.82 Thousand EUR | -1.15% |
| 2022 Q2 | 207.21 Thousand EUR | 100.0% |
| 2022 Q1 | 103.6 Thousand EUR | -53.69% |
| 2022 FY | 935.21 Thousand EUR | 843.73% |
| 2022 Q4 | 409.65 Thousand EUR | 100.0% |
| 2021 FY | 99.09 Thousand EUR | -0.73% |
| 2021 Q1 | 70.7 Thousand EUR | -17.52% |
| 2021 Q4 | 223.73 Thousand EUR | 11.51% |
| 2021 Q3 | 200.64 Thousand EUR | 41.89% |
| 2021 Q2 | 141.4 Thousand EUR | 100.0% |
| 2020 Q1 | 156.86 Thousand EUR | 0.0% |
| 2020 Q4 | 85.72 Thousand EUR | 0.0% |
| 2020 FY | 99.82 Thousand EUR | 45.88% |
| 2020 Q3 | 85.72 Thousand EUR | -45.35% |
| 2020 Q2 | 156.86 Thousand EUR | 0.0% |
| 2019 FY | 68.42 Thousand EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Affluent Medical SA | 1.22 Million EUR | 63.353% |
| Bluelinea Société Anonyme | 9826.00 EUR | -4465.001% |
| Carmat SA | 2.84 Million EUR | 84.25% |
| Diagnostic Medical Systems S.A. | 42.15 Million EUR | 98.936% |
| Euromedis Groupe | 37.42 Million EUR | 98.802% |
| Eurobio Scientific Société anonyme | 130.64 Million EUR | 99.657% |
| Implanet S.A. | 7.44 Million EUR | 93.977% |
| Median Technologies SA | 22.22 Million EUR | 97.982% |
| SpineGuard SA | 4.31 Million EUR | 89.599% |
| Theraclion SA | 1.82 Million EUR | 75.384% |
| Euroapi S.A. | 1.01 Billion EUR | 99.956% |
| Guerbet SA | 785.69 Million EUR | 99.943% |